Therapeutic use of RM1antigen

Details for Australian Patent Application No. 2005221207 (hide)

Owner Shaker Corporation

Inventors McKnight, Mike; Chakrabarti, Subhra; Glassy, Mark; Mukerjee, Sonjoy

Agent Davies Collison Cave

Pub. Number AU-B-2005221207

PCT Pub. Number WO2005/086967

Priority 60/552,656 11.03.04 US

Filing date 11 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 20 May 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 2/00 (2006.01) Peptides of undefined number of amino acids

C07K 4/00 (2006.01) Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/086967 Priority application(s): WO2005/086967

6 August 2009 Assignment before Grant

  Shantha West, Inc. The application has been assigned to Shaker Corporation

20 May 2010 Application Accepted

  Published as AU-B-2005221207

16 September 2010 Standard Patent Sealed

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221208-Substituted 5,12-diaza-benzoanthracene analogues

2005221199-Wind powered turbine in a tunnel